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Dissemination of Acinetobacter baumannii strains
harboring class D b-lactamases producing resis-
tance to carbapenem antibiotics severely limits our
ability to treat deadly Acinetobacter infections. Sus-
ceptibility determination in the A. baumannii back-
ground and kinetic studies with a homogeneous
preparation of OXA-23 b-lactamase, the major car-
bapenemase present in A. baumannii, document
the ability of this enzyme to manifest resistance to
last-resort carbapenem antibiotics. We also report
three X-ray structures of OXA-23: apo OXA-23 at
two different pH values, and wild-type OXA-23 in
complex with meropenem, a carbapenem substrate.
The structures and dynamics simulations reveal an
important role for Leu166, whose motion regulates
the access of a hydrolytic water molecule to the
acyl-enzyme species in imparting carbapenemase
activity.
INTRODUCTION
Regarded as of little clinical importance merely a decade ago,
Acinetobacter baumannii has evolved to become amajor oppor-
tunistic pathogen. It has spread rapidly throughout the world,
and 50%–70% of all A. baumannii clinical isolates are multidrug
resistant (Kallen et al., 2010; Rosenthal et al., 2010). A subclass
of b-lactam antibiotics, the carbapenems, which include the
archetypical imipenem along with meropenem and doripenem
(Figure S1A available online), have been successfully utilized
as last-resort antibiotics for treatment of multidrug-resistant
Acinetobacter infections. Clinical selection and dissemination
of the carbapenem-resistant A. baumannii constitute a serious
threat, as the mortality rates from infections by such resistant
strains are high, often exceeding 50% (Abbo et al., 2007; Liver-
more et al., 2010).
The major mechanism of resistance to b-lactam antibiotics in
A. baumannii, and in other Gram-negative bacteria, is the pro-
duction of b-lactamases, which hydrolyze the b-lactam moiety
of the antibiotics and render them inactive. Based on their aminoChemistry & Biology 20, 1107–111acid sequences, b-lactamases are divided into four classes
(Massova and Mobashery, 1998). Classes A, C, and D are
active-site-serine b-lactamases, whereas those of class B are
zinc dependent. Although carbapenemase activity could emerge
from any of the four classes of b-lactamases, in the case of
A. baumannii it is the production of class D enzymes (also known
as OXA-type b-lactamases) (Queenan and Bush, 2007; Walther-
Rasmussen and Høiby, 2006).
Currently, over 250 individual class D b-lactamases have been
reported. They are characterized by a high degree of structural
diversity and a wide-ranging antibiotic-resistance spectrum.
Although the active site of class D enzymes strongly resembles
that of class A enzymes, with an active-site serine experiencing
acylation by the b-lactam antibiotic and a structurally conserved
lysine residue nearby that promotes this process, the mecha-
nisms of b-lactam hydrolyses by the two classes of enzymes
differ markedly. In the class D enzymes, acylation and deacyla-
tion steps are facilitated by the conserved lysine residue, which
isN-carboxylated in a posttranslational step (Golemi et al., 2001;
Schneider et al., 2009a). Class D enzymes that are capable
of hydrolyzing carbapenem antibiotics are referred to as carba-
penem-hydrolyzing class D b-lactamases (CHDLs). Several
CHDLs, including OXA-23, OXA-40 (previously known as
OXA-24), OXA-51, and OXA-58 enzymes, have been identified
in A. baumannii (Afzal-Shah et al., 2001; Bou et al., 2000; Corvec
et al., 2007; Poirel et al., 2005). Among them, the OXA-23
b-lactamase is recognized as the major source of carbapenem
resistance in this deadly pathogen due to the worldwide dissem-
ination of OXA-23-producing Acinetobacter isolates (Mugnier
et al., 2010; Poirel et al., 2010).
Despite their immense clinical importance, CHDLs from
A. baumannii are poorly studied and currently structural informa-
tion is available for only one enzyme, OXA-24. Based on the
structure of apo OXA-24, it was proposed that the ability of the
enzyme to hydrolyze carbapenems is facilitated by a tunnel-
like entrance to the active site formed by the side chains of
residues Tyr112 and Met223 (OXA-24 residue numbering) (San-
tillana et al., 2007). It was suggested that this tunnel structure
forms a hydrophobic barrier, which gives access to the active
site only to certain substrates. The structures of two deacyla-
tion-deficient mutants of OXA-24 in complex with the carbape-
nem antibiotic doripenem have subsequently demonstrated
that this tunnel-like structure remains largely unchanged upon
binding of the antibiotic (Schneider et al., 2011). Comparison of5, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1107
Table 1. MICs of Carbapenem Antibiotics against A. baumannii
Antibiotic
MIC (mg/ml)
A. baumannii
ATCC 17978
A. baumannii ATCC
17978 + OXA-23
Fold
Increase
Imipenem 0.125 16 128
Meropenem 0.5 64 128
Ertapenem 4 256 64
Doripenem 0. 5 32 64
Table 2. Kinetic Parameters for Hydrolysis of Carbapenems by
OXA-23
Parameter Imipenem Meropenem Ertapenem Doripenem
kcat (s
1) 0.35 ± 0.01 0.068 ±
0.001
0.021 ±
0.001
0.036 ± 0.001
Km (mM) 4.8 ± 0.3 %1 0.50 ± 0.10 0.70 ± 0.09
kcat/Km
(M1 s1)
(7.4 ± 0.4) 3
104
R6.8 3
104
(4.2 ± 0.8) 3
104
(5.2 ± 0.7) 3
104
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Crystal Structure of OXA-23these structures with that of a noncarbapenemase OXA-1 com-
plexed with doripenem has shown that the pyrroline ring of car-
bapenem antibiotics in OXA-1 and OXA-24 is present in two
alternative tautomeric forms. The two tautomers are the D2-
tautomer with the pyrroline ring in an enamine form (Figure S1B)
and a D1-tautomer, where the pyrroline ring is in an imine form
(Figures S1C and S1D). It was concluded that the tunnel-like
structure of OXA-24 facilitates the formation of the D2-tautomer
of the pyrroline ring of doripenem, which could be the
catalytically competent isomer (Schneider et al., 2011). There
could be two potential reasons for this: one is a more favorable
spatial disposition of the hydroxyethyl moiety that allows the
ingress of a water molecule into the active site or, alternatively,
the existence of the enaminemoiety, which can serve as a proton
shuttle in promotion of a water molecule for deacylation
(Schneider et al., 2011). However, this tunnel is absent in the
OXA-48 apo enzyme from Klebsiella pneumoniae, the only other
class D carbapenemase whose X-ray structure is currently avail-
able (Docquier et al., 2009). These findings raise a question as to
whether class D enzymes utilize common structural elements
such as the hydrophobic tunnel to hydrolyze carbapenem antibi-
otics, or whether carbapenemase activity in various members of
this b-lactamase family has evolved independently (Docquier
et al., 2009).
To gain further insights into the structural basis of the carbape-
nemase activity in class D b-lactamases, we determined three
X-ray crystal structures for the major carbapenemase of
A. baumannii, OXA-23. Here, we report the structures of apo
OXA-23 crystallized at pH values of 4.1 and 7.0 and the OXA-
23 complex with meropenem. The latter represents the structure
of a wild-type class D carbapenemase with a clinically important
carbapenem antibiotic bound in the active site, allowing us to
observe the interaction between the substrate and a nonmutant
enzyme. The kinetics of turnover of carbapenems by OXA-23,
the respective X-ray structures, and the associated molecular
dynamics simulations provide a detailed characterization of
this clinically important enzyme from a problematic pathogen.
RESULTS AND DISCUSSION
Resistance Profile and Enzyme Kinetics of OXA-23
The OXA-23 b-lactamase has recently emerged as the major
class D carbapenemase ofA. baumannii, a notorious nosocomial
pathogen. Rapid spread of OXA-23-producing pathogens in
clinics worldwide constitutes a serious threat to human health.
OXA-23 confers resistance to the last-resort carbapenem antibi-
otics and thus significantly compromises the ability to treat
deadly A. baumannii infections. Despite its significant clinical1108 Chemistry & Biology 20, 1107–1115, September 19, 2013 ª201importance, the enzyme has not been studied in detail. To eval-
uate the ability of OXA-23 to produce resistance in A. baumannii,
we cloned its gene into a shuttle vector and introduced it into the
susceptible A. baumannii ATCC 17978 strain and subsequently
evaluated the minimal inhibitory concentrations (MICs) of four
clinically used carbapenem antibiotics. Production of OXA-23
in the background strain of A. baumannii ATCC 17978 increased
MICs of imipenem and meropenem 128-fold and those of dori-
penem and ertapenem 64-fold (Table 1). The resulting MIC value
for imipenem (16 mg/ml) corresponds to that reported for the
clinical isolate in which the OXA-23 b-lactamase was identified
for the first time (Paton et al., 1993). The MICs for three other
antibiotics conferred by OXA-23 were even higher: 32, 64, and
256 mg/ml for doripenem, meropenem, and ertapenem, respec-
tively. All these MIC levels are clinically important and define the
host strain producing OXA-23 as resistant to carbapenems.
As these high MIC values were observed in the susceptible
A. baumannii ATCC 17978 strain, existence of additional resis-
tance mechanisms such as low outer-membrane permeability
or efflux pumps in various clinical Acinetobacter isolates would
even further elevate resistance, indicating that carbapenem
antibiotics cannot be used for treatment of infections caused
by the OXA-23-producing A. baumannii.
Homogeneously pure enzyme was used to evaluate the
steady-state kinetic parameters for turnover of these carbape-
nems by OXA-23. The catalytic efficiency (kcat/Km) of the enzyme
against meropenem wasR6.83 104 M1 s1, and against three
other carbapenems was in the range of 4.2 3 104 to 7.4 3 104
M1 s1 (Table 2). OXA-23 had 5- to 16-fold higher turnover
numbers (kcat) and 7-fold or greater higher Km values for
imipenem than for the three other carbapenem antibiotics.
A. baumannii exhibits low permeability of its envelope for various
antibiotics (Clark, 1996; Vila et al., 2007). This low permeability
combined with the levels of catalytic activity that we measured
for turnover of imipenem, meropenem, doripenem, and ertape-
nem translates into high-level clinical resistance of the bacterium
to carbapenem antibiotics.
Crystal Structures of OXA-23 at Low and Neutral pH
Despite its recognized clinical importance, no structural informa-
tion was available for OXA-23. We have determined three OXA-
23 structures, two of the apo enzyme at pH values of 4.1 and 7.0
and a third of an acylated species with a carbapenem antibiotic
(meropenem). The resolution of the structure at two different
pH values was critical for the observation of the posttranslational
modification of the active-site Lys82. The side chain of this lysine
in class D b-lactamases is N-carboxylated in vivo (Golemi et al.,
2001), a modification that is critical for enzyme function. At
pH 4.1, Lys82 should undergo complete N-decarboxylation3 Elsevier Ltd All rights reserved
Figure 1. Ribbon Representation of the Superimposition of OXA-23
at pH 4.1 and pH 7.0
Loops that show large-scale structural rearrangements are shown at the lower
right, in the ‘‘open’’ conformation at pH 4.1 (green) and in the ‘‘closed’’
conformation at pH 7.0 (magenta). The loop that corresponds topologically to
the U loop in class A b-lactamases is also indicated. Meropenem (yellow ball-
and-stick representation) is shown in the active site of OXA-23. See also
Figures S1 and S4 and Tables S2 and S3.
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Crystal Structure of OXA-23(Golemi et al., 2001), and this is what is observed in our X-ray
structure. At the higher pH of 7.0, the enzyme retains the
N-carboxylation on the lysine, and hence the two structures
provide information for both states of this catalytically important
residue. Moreover, we were able to capture the substrate in the
active site of OXA-23 by cocrystallization at low pH. At low pH,
the catalytic lysine is readily N-decarboxylated and thus the
acyl-enzyme species is trapped and unable to efficiently un-
dergo hydrolysis. This allowed us to obtain structural information
on the acyl-enzyme species for the substratemeropenem bound
covalently to the wild-type enzyme.
The OXA-23 protein folds as two noncontiguous domains, a
mixed-a/b domain with two a helices and a six-stranded b sheet,
and an all-a domain, with the active site located at the junction
of the two domains (Figure 1). The overall OXA-23 structure is
similar to other members of the class D b-lactamases, including
the carbapenemases OXA-24 (Schneider et al., 2011) and OXA-
48 (Docquier et al., 2009) and the noncarbapenemases OXA-1
(Schneider et al., 2009b; Sun et al., 2003), OXA-2 (Protein Data
Bank [PDB] ID code 1K38), OXA-10, the first of the class D
enzymes whose structures were determined (Golemi et al.,
2000; Paetzel et al., 2000), OXA-13 (Pernot et al., 2001), and
OXA-46 (Docquier et al., 2010). Superimposition of the pH 7.0
form of OXA-23 with the class D b-lactamases whose structures
have been determined is summarized in Table S1. The root-
mean-square deviations (rmsds) in the positions for all matching
Ca atoms range from 0.6 A˚ for OXA-24 to 1.5 A˚ for OXA-1.
Inspection of the superimposed structures shows that the differ-
ences in the rmsd values are primarily due to length and confor-
mational differences in several external loops. When these loops
are omitted, the fit is greatly improved in all cases (Table S1),
indicating that the core regions of the OXA enzymes, comprisingChemistry & Biology 20, 1107–111the domain 1 b sheet and the domain 2 a helices, are structurally
conserved. Moreover, the rmsd values for all of the OXA struc-
tures, with the exception of OXA-24, are all very similar at around
1 A˚ (Table S1). OXA-24 is significantly closer in structure to
OXA-23 with an rmsd of 0.4 A˚, consistent with the much higher
sequence identity (65%) between these two A. baumannii
enzymes when compared to the lower sequence identities
(24%–38%) with other class D enzymes from different bacterial
species (Table S1). The regions of the superimposed structures
that show the greatest conformational variation are in the C-ter-
minal helix (a9), the loops between strands b1 and b2, strands b6
and b7, and between strand b9 and helix a9. Along with a long
unstructured U loop (which the class D enzymes have in com-
monwith the class A enzymes), these three loops are all adjacent
to the active site. In OXA-24 the b6/b7 loop carries the methio-
nine residue (Met223), which forms one side of the tunnel struc-
ture, and this residue is conserved in OXA-23 but in none of the
other OXA enzymes. Moreover, this loop comprising six residues
has a conserved structure in the three carbapenemases,
although OXA-48 lacks the conserved methionine and does
not have the tunnel structure, as has been noted previously
(Docquier et al., 2009). In OXA-10 and OXA-13, the b6/b7 loop
is three residues longer and folds away from the active site,
whereas in OXA-2 and OXA-46 it contains only two residues. In
a recent study with OXA-10 (De Luca et al., 2011), this loop
was replaced with the corresponding loops from OXA-23,
OXA-24, andOXA-48. All three loopmutants acquired significant
activity toward imipenem, and the structures of the OXA-10
enzyme with loops from OXA-24 and OXA-48 showed that the
b6/b7 loop adopted the conformation of the parental enzymes.
The b9/a9 loop shows much greater variation in structure and,
given its close proximity to the active site, may participate in
anchoring the bound substrates.
The low-pH form of OXA-23, refined at 1.15 A˚ resolution, has a
fully occupied citrate anion at the position where a carbapenem
substrate would be expected to bind. The two terminal carbox-
ylate groups of the citrate occupy an oxyanion hole formed by
the amide nitrogen atoms of the conserved active-site serine
Ser79 and Trp219 from strand b6 and the substrate carboxylate
binding site formed by the side chain of Arg259 (Figure S2A). As
indicated above, this low-pH form of the enzyme shows no evi-
dence of posttranslational N-carboxylation of the active-site
Lys82 (Figure S3), typically observed in all OXA enzymes (Golemi
et al., 2001). Attempts to displace the citrate from the low-pH
form by diffusing substrates into the preformed crystals proved
unsuccessful, and this could be due to either tight binding of
the citrate or the lack of the modified lysine residue, which is
thought to also be responsible for catalyzing the acylation
step. In contrast, analysis of the residual difference electron den-
sity in the active site of the neutral-pH form showed that the
active site was occupied only by water molecules, and there
was clear evidence that the side chain of Lys82 was modified
by N-carboxylation (Figure S2B).
Superimposition of the two apo OXA-23 structures shows that
at low pH, major structural rearrangements take place involving
two loops adjacent to the active site. The loop between helices
a4 and a5 (residues Leu125–Pro129) swings away from the
active site by approximately 3.5 A˚. Subsequently, a large surface
loop between helices a3 and a4 (residues Trp103–Met117)5, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1109
Figure 2. Meropenem Binding to OXA-23
(A) Residual Fo  Fc electron density (pink) in
the OXA-23 active site modeled with the final
coordinates of meropenem (cyan ball-and-stick
representation). Final 2Fo  Fc electron density for
Ser79 is indicated.
(B) Meropenem bound in the active site in the final
model showing hydrogen-bonding interactions
(dashed black lines).
See also Figure S2.
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Crystal Structure of OXA-23adopts an entirely different conformation, moving approximately
10–12 A˚ out into the solvent into an ‘‘open’’ conformation relative
to its ‘‘closed’’ position in the neutral-pH form (Figure S4).
Although such major loop movements are unusual in class D
b-lactamases, they are not unprecedented, because similar
movements of the a3/a4 and a4/a5 loops were also observed
in the OXA-46 structure (Docquier et al., 2010). Here, the confor-
mational changes appear to be in response to the presence in
the active site of a tartrate anion, positioned in approximately
the same location as the citrate in OXA-23.
The Meropenem Complex of Wild-Type OXA-23
The structure of the OXA-23-meropenem complex at pH 4.1 was
solved by molecular replacement (MR) using both the low- and
neutral-pH forms of apo OXA-23 as starting models. The two
MR solutions were comparable, but upon inspection of the elec-
tron density it was noted that the mobile a3/a4 and a4/a5 loops
were in the same closed conformation as seen in the neutral-pH
form, so this solution was chosen for subsequent refinement.
Superimposition of the two independent molecules in the asym-
metric unit gives an rmsd of 0.3 A˚ for 241 matching Ca atoms.
There are no significant differences in the surface loops between
the two molecules, although analysis of the crystal-packing
contacts of the two molecules shows that the specifics of the
symmetry-related interactions differ somewhat. Although both
molecules are in contact with a large solvent-filled cavity, mole-
cule A is surrounded almost on all sides by eight symmetry-
related molecules, whereas molecule B only makes contact
with four and appears much more solvent exposed. This varia-
tion in crystal contacts may account for the higher average
atomic displacement parameters for molecule B compared to1110 Chemistry & Biology 20, 1107–1115, September 19, 2013 ª2013 Elsevier Ltd All rights rmolecule A (Table S3). Inspection of the
crystal packing also shows that the
a3/a4 loop in both molecules is adjacent
to the solvent-filled cavity, and modeling
the open low-pH conformation of the
loop taken from the apoOXA-23 structure
onto the meropenem-OXA-23 structure
indicates that there would be adequate
space available for the complex to adopt
the open form without steric clashes
with neighboring molecules. Similarly,
an analysis of the crystal packing in the
low- and neutral-pH forms shows that
the conformation of the a3/a4 loop is
not constrained in either structure by
crystal packing. The mechanistic role ofthis loop motion is not clear at present and may simply be in
response to the presence of the citrate in the active site, as
was suggested for OXA-46, where tartrate was bound in the
active site (Docquier et al., 2010).
Meropenem was located in the OXA-23 active site in strong
residual Fo  Fc difference electron density, which was contin-
uous with the 2Fo  Fc density for the Ser79 side chain (Fig-
ure 2A). Meropenem is covalently bound to the Og atom of
Ser79 and anchored by seven hydrogen-bonding interactions
along with a number of hydrophobic packing contacts (Fig-
ure 2B). The C7 carbonyl oxygen, formerly the b-lactam
carbonyl, is located in the oxyanion hole and is hydrogen bonded
to the amide nitrogen atoms of Ser79 and Trp219, and the
carboxylate forms three hydrogen bonds with the side chains
of Thr217 and Arg259. There are two additional hydrogen bonds
to well-ordered water molecules. Two conserved residues at the
end of the long a3/a4 loop (Phe110 and Trp113) provide aro-
matic packing contacts with the pyrrolidine ring of meropenem.
One of these residues, Phe110, participates in the formation of
the tunnel-like structure, suggested to be important for the car-
bapenemase activity of the OXA-24 b-lactamase (Schneider
et al., 2011).
The quality of the electron density for meropenem was such
that all 26 nonhydrogen atoms of the substrate could be as-
signed unambiguously in the density, and even in the early
stages of refinement it was evident that the C3 carbon of the pyr-
roline ring was sp3 hybridized with the sulfur on the Si face of the
ring, such that the ring was in the D1-tautomeric state as the S
stereoisomer (Figure S1D). This was in contrast to the configura-
tion of the pyrroline ring in the OXA-24-doripenem complex
(Schneider et al., 2011), where the D2-tautomer was observedeserved
Figure 3. Stereoview of the Superposition
of the Acyl-Enzyme Intermediate in OXA-
23, OXA-24, and OXA-1
The two hydrophobic residues that interact with
the 6a-hydroxyethyl moiety of the intermediate are
shown at the upper right (Leu166 for OXA-23 and
Leu161 for OXA-1) and lower right (Val128 for
OXA-23). The difference in conformation of the
leucine residue can be seen. The residues that
constitute the tunnel-like structure in the OXA
enzymes are indicated for OXA-23 (Phe110
and Met221). OXA-23, green; OXA-24, magenta;
OXA-1, white. See also Figure S3 and Table S1.
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Crystal Structure of OXA-23(Figure S1B) with an sp2-hybridized C3 carbon atom. It has been
proposed that the tunnel-like structure over the active site of
OXA-24 formed by residues Tyr112 and Met223 would interfere
with formation of the D1-tautomer of carbapenem antibiotics (as
observed in the OXA-1-doripenem complex) and thus is critical
for the carbapenemase activity of OXA-24 (Schneider et al.,
2011). In our OXA-23 structure a similar tunnel is formed by the
side chains of Phe110 and Met221 (Figure 3), but this does not
prevent the formation of the D1-tautomer, as is seen in the
OXA-23-meropenem complex. Moreover, this OXA-23 D1-
tautomer differs from the D1-tautomer described for the OXA-
1-doripenem complex (Schneider et al., 2009b), where the sulfur
atom projected toward the opposite face of the pyrroline, giving
the R stereoisomer at C3.
On the opposite side of the pyrroline ring, the 6a-hydroxyethyl
moiety at C6 is directed toward the side chains of two conserved
hydrophobic residues, Val128 and Leu166 (Figure 3). Both
residues are within the van der Waals contact distance of the
terminal carbon of the ethyl group. The oxygen atom of the
6a-hydroxyethyl moiety is directed away from the active-site
Ser79 residue and makes no hydrogen-bonding interactions
with the protein. This is consistent with what was observed
in the OXA-24-doripenem complexes, yet in contrast to the
noncarbapenemase OXA-1-doripenem complex, where the
6a-hydroxyethyl is found in two different conformations, both
have the hydroxyl oxygen directed toward the active-site serine
such that it makes hydrogen-bonding interactions with the
N-carboxylated Lys70. The lysine residue in OXA-1 forms a
network of hydrogen bonds, both to the doripenem and to other
amino acids (Ser120 and Trp160). Only one of these hydrogen-
bonding interactions, that to the conserved Trp165 (equivalent
to Trp160 on OXA-1), is observed in OXA-23. The equivalent res-
idue to Ser120 in OXA-1 is a tyrosine (Tyr131) in OXA-23, and the
side chain of this residue is directed away from the meropenem
binding site such that no hydrogen-bonding interaction is
possible. Thus, in OXA-23, our structural data show that
although a hydrophobic tunnel is formed by the side chains of
Phe110 and Met221, it does not necessarily force the carbape-
nem substrate to adopt a D2-tautomer and a specific orientation
of the 6-hydroxyethyl group, as has been suggested (Schneider
et al., 2011). We now show that the same tunnel structure can
lead to the formation of a D1-tautomer with the same 6-hydrox-
yethyl conformation as seen in OXA-24. There are clearly other
factors that serve to present an acylated carbapenem in the cor-
rect orientation in the active site for efficient deacylation, and ourChemistry & Biology 20, 1107–111data, along with the evidence from the OXA-48 structure that has
no tunnel, would suggest that the tunnel might have less impact
than previously suggested.
Comparison of the neutral-pH apo OXA-23 structure with the
OXA-23-meropenem complex shows that the aforementioned
Leu166 undergoes a conformational change upon meropenem
binding. In the apo structure, Leu166 is directed toward the
Val128 side chain, and the two hydrophobic side chains are
within 3.5 A˚ of each other. In the presence of meropenem the
leucine swings away from the 6a-hydroxyethyl moiety by
approximately 3 A˚, rotating 90 about the Ca-Cb bond and 60
about the Cb-Cg bond. This now places the leucine approxi-
mately 7 A˚ from Val128. In the OXA-1 complex with doripenem,
the ‘‘6a-hydroxyethyl pocket’’ is also flanked by the conserved
Val117 and Leu161. However, the OXA-1 Leu161 exists in the
same conformation seen for Leu166 in apo OXA-23, such that
there is a significant hydrophobic interaction with Val117. The
difference in the positioning of the conserved leucine side chain
in carbapenem complexes of OXA-1 and OXA-23 may play a
critical role in allowing the access of the hydrolytic water to the
N-carboxylated lysine to enable deacylation of the acyl-enzyme
species. In OXA-1 the location of the Leu161 side chain would
preclude the hydrolytic water from approaching the N-carboxyl-
ated Lys70 or the ester carbon of the acylated doripenem, by
effectively blocking access to the active site (Figure 4A), because
the only other access to the carbamylated lysine from the
external solvent is blocked by the hydroxyethyl group of the
acyl-enzyme intermediate. In contrast, when the OXA-23
Leu166 side chain adopts the different conformation, this opens
a channel to the corresponding N-carboxylated Lys82 and
allows a water molecule to approach the acyl-enzyme species
(Figure 4B).
This conserved leucine residue is in the U loop, and further
analysis of the OXA-1 and OXA-23 structures shows that this
loop has a slightly different structure in the two enzymes. There
is an insertion of a glutamate (Glu162) in OXA-1 directly following
Leu161, and this residue makes hydrogen-bonding interactions
with the side chains of Asn226 and Asp68, which serves to pull
the loop approximately 1 A˚ closer toward the b sheet than in
OXA-23 and OXA-24. If the OXA-1 Leu161 residue were to swing
upward in the same way as we observe in OXA-23, there would
be significant steric clash with the Asp68 side chain. Conversely,
in OXA-23, the equivalent residue to this aspartate is a valine
(Val67), Asn226 is replaced by another valine (Val227), and there
is an adjacent hydrophobic residue (Ile223), the side chain of5, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1111
Figure 4. Molecular Surface Representa-
tion of OXA-1 and OXA-23
(A) OXA-1.
(B) OXA-23.
In both cases the bound substrate (doripenem and
meropenem, respectively) is shown in cyan ball-
and-stick representation. The motion of the
Leu166 side chain in response to meropenem
binding in OXA-23 opens a channel to the external
solvent and allows access of a water molecule to
the N-carboxylated Lys82.
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Crystal Structure of OXA-23which occupies the site where the Glu162 residue was in OXA-1.
These two hydrophobic residues (Ile223 and Val227) are from the
b6/b7 loop, noted earlier as being important for the carbapene-
mase activity of the OXA enzymes (De Luca et al., 2011). In the
two other known class D carbapenemases (OXA-24 and OXA-
48) there are small hydrophobic residues that correspond
spatially to Ile223 and Val227 in the OXA-23 b6/b7 loop, due to
the similar fold of the loop in these three enzymes. The narrow-
spectrum OXA enzymes with their widely varying b6/b7 loop
structure do not retain these residues. The presence of these
residues in the carbapenemases contributes to the formation
of a hydrophobic pocket adjacent to Leu166 that would be
attractive to the movement of the leucine side chain. None of
the other OXA enzymes whose structures are known have as
extensive a hydrophobic pocket in this region, and may not be
capable of effecting the movement of the conserved leucine
side chain in the samemanner as we observe in OXA-23. In these
narrow-spectrum enzymes, without such a side-chain move-
ment, it is unlikely that a channel to the external solvent can be
opened, and the opportunity for a water molecule to enter the
site adjacent to the carbamylated lysine and effect deacylation
is minimized.
Molecular Dynamics Simulations of OXA-23 and OXA-1
These important experimental observations from the crystal
structures were complemented by MD simulations. The OXA-
23 and OXA-1 structures were acylated with meropenem and
N-carboxylated at their respective active-site lysine residues.
Both the D1- and D2-tautomers of meropenem were generated
independently for these MD simulations. Similar to what was
observed in the crystal structure of OXA-23, we see a move-
ment of the loop containing residues Trp103–Met117 during
the simulations. The movement is more pronounced with a
D2-meropenem tautomer, and appears to be synchronized
with the movement of the C2 substituent of the pyrroline ring.
The maximal separation between the two loop conformations
in the course of simulations was approximately 6 A˚. The mero-
penem molecules do not experience any significant movement.
Their average rmsds were approximately 0.8 A˚ and 1.3 A˚ for the
OXA-1 and OXA-23 simulations, respectively, with the bulk of
the contribution coming from the more inherently flexible C2
substituent. This differs from what was observed in OXA-48,
where in MD simulations the hydroxyethyl group of docked
meropenem was seen to rotate about 30 such that the methyl
group was accommodated in a hydrophobic pocket formed1112 Chemistry & Biology 20, 1107–1115, September 19, 2013 ª201by Leu158 (equivalent to Leu166 in OXA-23) and Thr213
(equivalent to Met221), thus allowing a closer approach of a
water molecule to the N-carboxylated lysine (Docquier et al.,
2009).
The OXA-23 simulations show a large number of snapshots
with a water molecule favorably positioned for deacylation (Fig-
ure 5). This would appear for two structural reasons. First, in
OXA-23 the N-carboxylated lysine is held by only two hydrogen
bonds, one with Trp165 and another with the 6a-hydroxyethyl
group of meropenem, whereas in OXA-1 one additional
hydrogen bond to Ser120 (OXA-1 numbering) can be seen (Fig-
ure S5). The extra hydrogen bond in OXA-1 pulls the lysine
approximately 1 A˚ in toward the active-site serine compared
to OXA-23, making it less accessible to water. In OXA-23 the
displacement of the less-restrained lysine farther from the
Ser79 side chain serves to create space for incomingwater. Sec-
ond, as seen in the crystal structures and discussed earlier, the
positioning of the Leu166 side chain is different between OXA-
23 and OXA-1 (Figure S5). In the OXA-23 simulations, movement
of the Leu166 side chain is observed such that it adopts an orien-
tation that opens a channel through which a hydrolytic water
molecule could pass and position itself for the deacylation
step. In the OXA-1 simulations this conserved leucine is not
mobile, and adopts a conformation that restricts access of water
into the active site.
We have already noted that a comparison of the OXA-23
structure with that of noncarbapenemase OXA-1 also pinpoints
these two significant structural differences in the active sites of
these enzymes, and suggest that they could play a key role in
the inability of OXA-1 to efficiently hydrolyze carbapenem anti-
biotics, in contrast to OXA-23. The additional hydrogen bond
seen in the OXA-1 MD simulations between the N-carboxylated
lysine and Ser120 is also observed in the OXA-1 structure, along
with the shift in the lysine side chain relative to its position in
OXA-23. This makes the OXA-1 N-carboxylated lysine less
accessible to a hydrolytic water. The second important differ-
ence between the two enzymes is the spatial disposition of
the conserved leucine (Leu166 in OXA-23 and Leu161 in
OXA-1). As observed by both X-ray crystallography and MD
simulation, binding of the carbapenem substrate in OXA-23
results in a significant movement of the conserved leucine, sta-
bilized by the presence of an adjacent hydrophobic pocket
created by the specific fold of the b6/b7 loop particular to class
D carbapenemases, which would then allow access of a water
molecule into the active site of the enzyme. In both the apo3 Elsevier Ltd All rights reserved
Figure 5. Molecular Dynamics Simulations
of OXA-23 and OXA-1
(A and B) Schematic of the active site of the acyl-
enzyme species of meropenem in (A) D2- and (B)
D1-tautomeric forms is shown.
(C and D) Distance distribution of the d1 and d2
during the 20 ns simulation of OXA-23 (black) and
OXA-1 (red) acylated with meropenem in (C) D2-
and (D) D1-tautomeric forms. See also Figure S5.
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biotic, this conserved leucine residue does not move and thus
limits access of a hydrolytic water to the carbapenem-acylated
active-site serine.
The ramification of this observation has direct bearing on
whether an enzyme can function as a carbapenemase (as in
OXA-23) or not (as in OXA-1). In the latter case acylation takes
place, but the complex experiences deacylation only ineffi-
ciently. This case is very similar to that of class A b-lactamases
for which carbapenems are poor substrates, behaving tran-
siently as inhibitors (Maveyraud et al., 1998). In the evolution of
the OXA-23 enzyme as a carbapenemase, it had to overcome
energetic barriers to become catalytically more competent for
turnover of these substrates. Our kinetic data and evaluation
of antibiotic susceptibility patterns fully support this as the
outcome in the case of OXA-23, but the enabling mechanism
would not appear to be merely a single obvious mutation. It is
likely to be the culmination of multiple amino acid changes
in the sequence of the protein. Nonetheless, the critical
outcome, the motion of Leu166 to allow entry of the water mole-
cule to the active site, may be an indispensable component of
the function of this enzyme.
SIGNIFICANCE
Merely a decade ago, carbapenems were the antibiotics of
choice for treatment of infections caused by multidrug-
resistant Acinetobacter baumannii, a notorious nosocomial
pathogen. However, resistance to carbapenem antibiotics
now severely compromises therapeutic options against
deadly Acinetobacter infections. Antibiotic susceptibility,
kinetics, and X-ray structures of OXA-23, themajor carbape-
nemase in Acinetobacter, have been determined, giving us
insight into the molecular mechanism of carbapenemase
activity for this significant antibiotic-resistance enzyme in
an important human pathogen.Chemistry & Biology 20, 1107–1115, September 19, 2013EXPERIMENTAL PROCEDURES
Cloning
The gene encoding the class D b-lactamase OXA-
23 from A. baumannii (GenBank accession number
CAB69042.1) with its leader sequence and a pro-
moter provided by the ISAbaI insertion sequence
was custom synthesized and cloned into the shut-
tle vector pNA1, which was constructed in our lab
and is interchangeably useful for transformation
of either Escherichia coli or A. baumannii. The
construct was first introduced into the competent
E. coli JM83 strain by transformation. The
construct then was reisolated from E. coli andsequenced and electroporated into the A. baumannii ATCC 17978 strain for
subsequent antibiotic susceptibility testing.
For large-scale protein expression and purification, the gene for OXA-23
was optimized for expression in E. coli and custom synthesized. Nucleotides
encoding the 17 amino acid leader sequence of OXA-23 were deleted, and
the NdeI and HindIII restriction sites were introduced at the 30 and 50 ends of
the gene for the mature enzyme, respectively. The gene was subsequently
cloned into the NdeI/HindIII restriction sites of the pET24a(+) vector (Invitro-
gen) and transformed into E. coli BL21 (DE3) competent cells.
Antibiotic Susceptibility Testing
Minimal inhibitory concentrations of four carbapenem antibiotics, imipenem,
meropenem, doripenem, and ertapenem, against the susceptible strain of
A. baumannii ATCC 17978 and A. baumannii ATCC 17978 harboring shuttle
vector expressing OXA-23 b-lactamase were determined according to Clinical
and Laboratory Standards Institute guidelines (Clinical and Laboratory Stan-
dards Institute, 2009). Bacteria were used at a final inoculum of 53 105 cfu/ml
in Mueller-Hinton II broth (Difco). The experiment was performed in triplicate
and results were interpreted after incubation at 37C for 16–20 hr.
Protein Purification
Fivemilliliters of overnight culture of E. coliBL21 (DE3) harboring the pET24a(+)
vector encoding the OXA-23 b-lactamase was inoculated into 500 ml of fresh
LB broth supplemented with 60 mg/ml of kanamycin. The cells were grown at
37Cwith shaking (180 rpm) until an OD600 of 0.8 was reached. Protein expres-
sion was induced by the addition of isopropyl b-D-thiogalactopyranoside to a
final concentration of 1 mM. The cells were incubated at 22C for 20 hr with
shaking (180 rpm), pelleted by centrifugation at 18,000 3 g for 30 min at
room temperature, resuspended in 40 ml of 20 mMMES (pH 6.0), and disrup-
ted by sonication. The cell extract was centrifuged at 18,0003 g for 1 hr at 4C
to remove insoluble debris. The supernatant was loaded onto a DEAE anion-
exchange column (Bio-Rad) equilibrated with the same buffer. The flow-
through, containing the enzyme, was recovered and dialyzed against 20 mM
Tris buffer (pH 8.0). The flowthrough was loaded onto a High Q anion-
exchange column (Bio-Rad) equilibrated with the same buffer. The column
was washed with two volumes of 20 mM Tris (pH 8.0) and the protein was
eluted with a linear gradient of 0–500 mM NaCl. Fractions were analyzed for
the presence of b-lactamase by the addition of the chromogenic substrate
nitrocefin and subsequently by SDS-PAGE. Fractions containing the protein
were pooled and dialyzed against HEPES buffer (pH 7.5). Protein purity was
assessed by SDS-PAGE and estimated to be greater than 95%.ª2013 Elsevier Ltd All rights reserved 1113
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All kinetic data were obtained using either a Cary 50 or Cary 60 spectropho-
tometer (Varian or Agilent, respectively) at 22C. Nonlinear regression was per-
formed to fit the data using Prism (GraphPad Software). Data were collected
from at least three independent measurements. Reactions containing
100 mM NaPi (pH 7.0), 50 mM NaHCO3, and varying concentrations of carba-
penem substrate (2–100 mM)were initiated bymixing with OXA-23 (0.1–2 mM in
20 mM HEPES [pH 7.5]). The absorbance was monitored to follow the course
of each reaction at the following wavelengths: ertapenem (l = 295 nm and Dε =
10,940 cm1M1), doripenem (l = 299 nm andDε =11,540 cm1M1), imi-
penem (l = 297 nm andDε =10,930 cm1 M1), andmeropenem (l = 298 nm
and Dε = 7,200 cm1 M1). The linear portion of each reaction was used to
determine the steady-state velocities (v). The steady-state parameters, kcat
and Km, were calculated by plotting the observed rate constants (kobs =
v/[E]) as a function of carbapenem concentration and fitting the data nonli-
nearly to the Michaelis-Menten equation.
Crystallization and Data Collection
An initial screen was made using PEG/Ion Screens 1 and 2 (Hampton
Research) using the sitting-drop method and a protein concentration of
35 mg/ml. Crystals were obtained in a number of wells, and subsequent
refinement of the conditions gave diffraction-quality crystals at low pH
from 0.06 M citric acid, 0.04 M bis-Tris propane (pH 4.1), 16% PEG3350,
and at neutral pH from 0.2 M succinic acid (pH 7.0), 20% PEG3350. The
OXA-23-meropenem complex was formed by incubating 950 mM enzyme
with 10 mM meropenem at 4C and crystallizing the resultant complex
from 0.06 M citric acid, 0.04 M bis-Tris propane (pH 4.1), 16% PEG3350.
Complete diffraction data sets were collected from single crystals of OXA-
23 at pH 4.1 and pH 7.0 using Stanford Synchrotron Radiation Lightsource
beamline BL12-2. The crystals diffracted to 1.15 A˚ and 2.4 A˚ resolution,
respectively. The pH 4.1 data set comprised 400 images with an oscillation
angle of 0.5 with X-rays at 14,000 eV (0.88557 A˚) using a PILATUS 6M
PAD detector running in shutterless mode. The pH 7.0 data set also
comprised 400 images with an oscillation angle of 0.5, with X-rays at
12,568 eV (0.97950 A˚). A single crystal of the OXA-23-meropenem complex
diffracted to 2.15 A˚ in space group P21. A total of 500 images using an oscil-
lation angle of 0.5 were collected at BL12-2. All images for the three struc-
tures were processed with XDS (Kabsch, 1993) and scaled with SCALA from
the CCP4 suite of programs (CCP4, 1994). Final data collection statistics are
given in Table S2.
Structure Solution and Refinement
The OXA-24 structure (PDB ID code 3GP4) was used as the search model in
the determination of the OXA-23 structure at pH 4.1 by molecular replace-
ment using MOLREP from the CCP4 suite (CCP4, 1994). All solvent molecules
were removed from the OXA-24 model prior to MR calculations, and the
CCP4 program CHAINSAW was used to convert the OXA-24 model into
OXA-23, whereby identical residues in the two sequences were retained
and those that differed were truncated at the Cb atom. A strong MR solution
gave the position of the single OXA-23 molecule in the C2 asymmetric unit.
The structure was refined for 15 cycles using REFMAC (Murshudov et al.,
1999) and 2Fo  Fc and Fo  Fc electron density maps were calculated.
During the course of the refinement, strong residual Fo  Fc density was
observed in the active site, and inspection of the crystallization conditions
suggested the presence of a citrate molecule, which was subsequently added
to the model. The fully refined OXA-23 pH 4.1 model was subsequently used
to solve the structure of OXA-23 at pH 7.0, and both of these apo structures
were used as MR models for the OXA-23-meropenem complex. In the latter,
meropenem molecules were built into the available electron density in the
active sites of both molecules in the asymmetric unit. Refinement of all three
structures was completed with the PHENIX suite of programs (Adams et al.,
2010) and manual building of the models with the molecular graphics program
Coot (Emsley and Cowtan, 2004). Water molecules were added in structurally
and chemically relevant positions in all three structures. The atomic displace-
ment parameters for the protein atoms were refined isotropically for the pH
7.0 and meropenem structures and anisotropically for the pH 4.1 structure.
Final refinement statistics are given in Table S3. Figures were generated using
PyMOL (DeLano, 2002).1114 Chemistry & Biology 20, 1107–1115, September 19, 2013 ª201Computational Methods
The OXA-23 crystal structure acylated with meropenem in the D1-tautomeric
form provided the initial atomic coordinates for the OXA-23 simulations. The
D2-tautomer of meropenem was modeled in using SYBYL-X (Tripos). For the
OXA-1 simulations, a previous OXA-1 structure acylated with doripenem
(PDB ID code 3ISG) provided the initial atomic coordinates for the protein,
and D1- and D2-meropenem tautomers were modeled in based on the ligand
conformations generated for OXA-23. Crystallographic waters for each
enzyme were retained. RESPmethodology (Bayly et al., 1993) provided partial
atomic charges for the acylated meropenem and serine, whereas Amber
(University of California, San Francisco) ff99 and gaff force fields provided
the rest of the partial atomic charges and all of the force-field parameters.
Both simulation systems were solvated in a truncated octahedral box of
explicit water molecules using the TIP3P water model (Jorgensen et al.,
1983). The MD simulations were started with a 5,000-step minimization of
the water molecules. This was followed by a heating phase to 300 K and an
equilibration stage for 200 ps. The data collection phase that followed was
20 ns long. The temperature was controlled using the Langevin method, and
isotropic position scaling provided pressure regulation. The simulations were
run using the Amber 12 package, and results were analyzed using its ptraj
module and VMD (Humphrey et al., 1996).
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The coordinates and structure factors for OXA-23-meropenem, OXA-23 pH
4.1, and OXA-23 pH 7.0 have been deposited in the Protein Data Bank under
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